VitaFLEX
Hyaluronic Acid
It is produced to relieve pain and complaints of limited articular mobility related to degenerative knee lesions and other synovial joints.
Produced to relieve pain and limited joint mobility complaints due to degenerative knee lesions and other synovial joints
Advantages
- Easy to Use
- Possibility of treatment at home
- Painless and routine procedure
- Significant reduction in pre-treatment complaints
- Improved quality of life
It is a balanced combination of chondroitin sulfate, sodium hyaluronate, and calcium chloride for intravesical use. It acts by temporarily covering the glycosaminoglycan (GAG) layer of the bladder, the surface of the transitional epithelium with a protective layer of chondroitin sulfate, which promotes recovery of the natural impermeable barrier function. It helps to relieve pain and reduce the frequency and urgency of urination. It causes a series of health problems that lead to the onset of various types of cystitis (eg, interstitial cystitis, infection-induced recurrent cystitis, antitumor-induced cystitis, radiation-induced cystitis, traumatic cystitis). It is a balanced combination of sodium hyaluronate, chondroitin sulfate, and calcium chloride. With the effect of calcium chloride in its content, it integrates functionally into the barrier and reorganizes the protective function of the barrier.
Detailed specifications
Sodium hyaluronan is obtained by bacterial fermentation and is used as a viscoelastic gel to reinforce intra-articular connective tissues. It is sterile and nonpyrogenic. Synovial fluid contains physiological hyaluronic acid, which is responsible for its viscoelastic properties that allow painless joint movements thanks to its lubricating properties. It also contributes to the nutrition of cartilage. After 3-5 intra-articular injections, joint mobility increases, and pain associated with degenerative lesions is relieved.
It is used according to the doctor's recommendation.
It is applied only by medical doctors.
It is produced to relieve pain and complaints of limited articular mobility related to degenerative knee lesions and other synovial joints.
Produced to relieve pain and limited joint mobility complaints due to degenerative knee lesions and other synovial joints
Advantages
- Easy to Use
- Possibility of treatment at home
- Painless and routine procedure
- Significant reduction in pre-treatment complaints
- Improved quality of life
| Order Number | Percent | Sodium Hyaluronic Acid | Volume | NaCl 0,9 % |
| OP1005 | 0,01 | 5.000 mg | 0.5 ml | 4.250 mg |
| OP1006 | 0,01 | 10.000 mg | 1.0 ml | 8.500 mg |
| OP1007 | 0,01 | 15.000 mg | 1.5 ml | 12.750 mg |
| OP1008 | 0,01 | 20.000 mg | 2.0 ml | 17.000 mg |
| OP1009 | % 1.6 | 8.000 mg | 0.5 ml | 4.250 mg |
| OP1010 | % 1.6 | 16.000 mg | 1.0 ml | 8.500 mg |
| OP1011 | % 1.6 | 24.000 mg | 1.5 ml | 12.750 mg |
| OP1012 | % 1.6 | 32.000 mg | 2.0 ml | 17.000 mg |
| OP1013 | % 2.2 | 11.000 mg | 0.5 ml | 4.250 mg |
| OP1014 | % 2.2 | 22.000 mg | 1.0 ml | 8.500 mg |
| OP1015 | % 2.2 | 33.000 mg | 1.5 ml | 12.750 mg |
| OP1016 | % 2.2 | 44.000 mg | 2.0 ml | 17.000 mg |
| OP1017 | % 3.0 | 15.000 mg | 0.5 ml | 4.250 mg |
| OP1018 | % 3.0 | 30.000 mg | 1.0 ml | 8500 mg |
| OP1019 | % 3.0 | 45.000 mg | 1.5 ml | 12.750 mg |
| OP1020 | % 3.0 | 60.000 mg | 2.0 ml | 17.000 mg |
